Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Tabula Rasa Healthcare (TRHC - Free Report) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
Tabula Rasa Healthcare is one of 763 companies in the Medical group. The Medical group currently sits at #11 within the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. TRHC is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for TRHC's full-year earnings has moved 148.89% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Based on the latest available data, TRHC has gained about 122.03% so far this year. In comparison, Medical companies have returned an average of 2.33%. As we can see, Tabula Rasa Healthcare is performing better than its sector in the calendar year.
Looking more specifically, TRHC belongs to the Medical Info Systems industry, a group that includes 22 individual stocks and currently sits at #80 in the Zacks Industry Rank. On average, stocks in this group have gained 8.92% this year, meaning that TRHC is performing better in terms of year-to-date returns.
Going forward, investors interested in Medical stocks should continue to pay close attention to TRHC as it looks to continue its solid performance.